Expected out-of-pocket costs for commonly prescribed brand name medications have grown substantially for Medicare Part D ...
Drug manufacturers remain steadfast in their efforts to challenge the constitutionality of the Inflation Reduction Act’s mandatory price ...
Expected out of-pocket costs for commonly prescribed brand name medications have grown substantially for Medicare Part D ...
Aurora Pharmaceutical is pleased to announce the availability of EquiCoxib, the FDA-approved generic equivalent of Equioxx® ...
It's the first time we're hearing from one of the plaintiffs accused of raising the price of an asthma inhaler out of reach ...
Shanon and William Schmidtknecht, of Poynette, say their 22-year-old son Cole was told the cost had jumped from $66 to $539 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results